Exhibit 32.1
                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


         In  connection  with the  Quarterly  Report  of  CytoGenix,  Inc.  (the
"Company")  on Form 1O-Q for the period  ended  June 30,  2008 as filed with the
Securities and Exchange  Commission on the date hereof (the "Report"),  I, Randy
Moseley, certify, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906
of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

     (1)The  Report fully  complies  with the  requirements  of section 13(a) or
     15(d) of the Securities Exchange Act of 1934; and

     (2)The information contained in the Report fairly presents, in all material
     respects, the financial condition and result of operations of the Company.

September 19, 2008


/s/ Randy Moseley
- -----------------
Randy Moseley
Interim Chief Executive Officer